Vanguard Capital Management
INO icon

Vanguard Capital Management’s Inovio Pharmaceuticals INO Stock Holding History

Vanguard Capital Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.02M Buy
3,650,562
+749,354
+26% +$889K ﹤0.01% 3197
2026
Q1 		$5.05M Buy
+2,901,208
New +$4.78M ﹤0.01% 3055

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's INO Position: Q2 2026 in Review

Vanguard Capital Management increased its Inovio Pharmaceuticals (INO) stake by 26% in Q2 2026, buying an estimated $889K and bringing the position to 3,650,562 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

Vanguard Capital Management first reported a position in INO in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.05M in Q1 2026. 105 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Vanguard Capital Management held 3,650,562 shares of Inovio Pharmaceuticals worth $4.02M as of Q2 2026.
  • Vanguard Capital Management bought 749,354 Inovio Pharmaceuticals shares in Q2 2026, an estimated $889K.
  • Inovio Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3197 holding.
  • Vanguard Capital Management first reported a position in Inovio Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Inovio Pharmaceuticals position peaked at $5.05M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.